(Q45189216)

10 December 2017

Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease (English)

1 reference

10 December 2017

0 references

1 reference

1 reference

1

1 reference

10 December 2017

2

1 reference

10 December 2017

5

Joel S Perlmutter

1 reference

10 December 2017

3

Johanna M Hartlein

1 reference

10 December 2017

4

Juanita L Carl

1 reference

PubMed ID

15602502

10 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

10 December 2017

Neuropsychopharmacology

1 reference

10 December 2017

30

1 reference

10 December 2017

3

1 reference

10 December 2017

590-601

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300632

10 December 2017

0 references

cites work

The duality of the cingulate gyrus in monkey. Neuroanatomical study and functional hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Rapid intravenous loading of levodopa for human research: clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Neuroimaging of cerebral activations and deactivations associated with hypercapnia and hunger for air.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Psychiatric aspects in Parkinsonism treated with L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Metabolic correlates of levodopa response in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Measuring the neuromodulatory effects of drugs in man with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Dopa-induced blood flow responses in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The use of the DSM-III-R Checklist for initial diagnostic assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Cognitive function and regional cerebral blood flow in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Activation of specific cortical regions by apomorphine: an [15O]H2O PET study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Prolactin and cortisol responses to fenfluramine in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

21 January 2018

The on-off phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Brain activation in PTSD in response to trauma-related stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Differential limbic--cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The retrosplenial cortex and emotion: new insights from functional neuroimaging of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

What do brain imaging studies tell us about anxiety disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Mood response to levodopa infusion in early Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Frontal lobe dysfunction in secondary depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Limbic-cortical dysregulation: a proposed model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Clinical and biochemical features of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

A probabilistic atlas of the human brain: theory and rationale for its development. The International Consortium for Brain Mapping (ICBM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Effect of apomorphine on the relationship between local cerebral glucose utilization and local cerebral blood flow (with an appendix on its statistical analysis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Regional cerebral blood flow in patients with Parkinson's disease under chronic levodopa therapy: measurements during "on" and "off" response fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Mood changes and "on-off" phenomena in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The Organization of Networks within the Orbital and Medial Prefrontal Cortex of Rats, Monkeys and Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Relationship between mood and motor fluctuations in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The hippocampus and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Hippocampal atrophy in recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Brain blood volume, flow, and oxygen utilization measured with 15O radiotracers and positron emission tomography: revised metabolic computations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Thalamic and Cortical Afferents Differentiate Anterior from Posterior Cingulate Cortex in the Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Spatial registration and normalization of images

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

Depression in Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

PET measurement of dopamine D2 receptor-mediated changes in striatopallidal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Dopamine D(1) agonist activates temporal lobe structures in primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Effect of L-DOPA on depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Reliability, validity, and clinical application of the Visual Analogue Mood Scale.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Parkinson's disease, depression, and the on-off phenomenon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

1 reference

7 January 2021

The spectrum of levodopa-related fluctuations in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Anxiety and motor performance in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

The Association of Ventral Tegmental Area Histopathology With Adult Dementia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300632

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300632

1 reference

PubMed ID

15602502

Dimensions Publication ID

10 December 2017

0 references

1 reference

PubMed ID

15602502